Rotenone, a causative drug of PD, was found to decrease nuclear NCL levels in a previous study [28], and our previous report has revealed that the overexpression of αSyn decreased NCL levels in the nucleus [10]. The gene discussed is NUCLEOLIN; the disease is Parkinson disease.